Peer-reviewedCC BY-NC-NDTranslational cancer research
FBXO17 regulates the malignant progression of colorectal cancer via the Wnt/β-catenin pathway
- 1Department of Clinical Laboratory Medicine , The Key Laboratory of Precision Medicine and Testing of Wenzhou , Wenzhou Central Hospital , Wenzhou , ;
- 2Department of Clinical Laboratory , The Second Affiliated Hospital of Zhejiang Chinese Medical University , Hangzhou ,
Related
- SURF4 regulates RRM2 to activate the PI3K/AKT pathway and promote malignant progression in hepatocellular carcinoma
- From inflammation to carcinogenesis: MiRNA regulates epithelial-mesenchymal transition to facilitate malignant progression of gastric precancerous lesions
- LncRNA RASAL2-AS1 serves as a potential biomarker for prognosis and regulates cellular processes via the miR-590-5p/PDCD5 axis and Wnt/β-catenin pathway in cervical cancer
- ACAN regulates VSMC mitochondrial homeostasis through the YAP1/TAZ pathway and contributes to the onset and progression of aortic dissection
- Integrated single-cell transcriptomics reveals miR-941 targets CLDN4 to inhibit malignant progression of thyroid cancer through the PI3K/AKT signaling pathway.
BibTeX
@article{tang2026fbxo17,
title = {{FBXO17 regulates the malignant progression of colorectal cancer via the Wnt/β-catenin pathway}},
author = {Enyan Tang and Yijie Xiao and Xiaohong Qian and Shufei Li and Bin Chen},
journal = {Translational cancer research},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13657844},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - FBXO17 regulates the malignant progression of colorectal cancer via the Wnt/β-catenin pathway
AU - Enyan Tang
AU - Yijie Xiao
AU - Xiaohong Qian
AU - Shufei Li
AU - Bin Chen
PY - 2026
DA - 2026/08/28
JO - Translational cancer research
UR - https://europepmc.org/article/PMC/PMC13657844
SN - 2218-676X
ER -